Search research articles
Contact Us
Filters
Showing results (71-80 of 109) with videos related to
Page
of 11
Sort By:
Bone Marrow Transplantation
|
May 21, 2020
Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance
Hilit Levy-Barazany, Liat Shachnai-Pinkas, Galina Rodionov, et al.
International Journal of Molecular Sciences
|
May 14, 2025
GMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated <i>EZH2</i> and <i>TP53</i> at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses
Tal Shahar Gabay, Nofar Stolero, Niv Rabhun, et al.
The Journal of Clinical Investigation
|
November 16, 2023
Chronic graft-versus-host disease detected by tissue-specific cell-free DNA methylation biomarkers
Batia Avni, Daniel Neiman, Elior Shaked, et al.
Acta Haematologica
|
May 23, 2024
Eosinophilic Pleocytosis in the Cerebrospinal Fluid following CAR-T Cell Therapy for Central Nervous System Lymphoma: A Case for Warning?
Mayasa Abu Ata, Israel Henig, Dana Yehudai-Ofir, et al.
Cancer
|
December 2, 2016
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Norbert-Claude Gorin, Myriam Labopin, Tomasz Czerw, et al.
Bone Marrow Transplantation
|
December 16, 2020
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Jaime Sanz, Myriam Labopin, Miguel A Sanz, et al.
Blood Advances
|
December 5, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study
Ofir Wolach, Itai Levi, Boaz Nachmias, et al.
European Journal of Haematology
|
March 25, 2023
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study
Ofrat Beyar Katz, Chava Perry, Sigal Grisariu-Greenzaid, et al.
Bone Marrow Transplantation
|
September 22, 2022
Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)
Eleni Gavriilaki, Myriam Labopin, Ioanna Sakellari, et al.
Haematologica
|
November 21, 2024
Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing
Yael Morgenstern, JongBok Lee, Yoosu Na, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 109) with videos related to
Sort By:
Page
of 11
Bone Marrow Transplantation
|
May 21, 2020
Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance
Hilit Levy-Barazany, Liat Shachnai-Pinkas, Galina Rodionov, et al.
International Journal of Molecular Sciences
|
May 14, 2025
GMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated <i>EZH2</i> and <i>TP53</i> at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses
Tal Shahar Gabay, Nofar Stolero, Niv Rabhun, et al.
The Journal of Clinical Investigation
|
November 16, 2023
Chronic graft-versus-host disease detected by tissue-specific cell-free DNA methylation biomarkers
Batia Avni, Daniel Neiman, Elior Shaked, et al.
Acta Haematologica
|
May 23, 2024
Eosinophilic Pleocytosis in the Cerebrospinal Fluid following CAR-T Cell Therapy for Central Nervous System Lymphoma: A Case for Warning?
Mayasa Abu Ata, Israel Henig, Dana Yehudai-Ofir, et al.
Cancer
|
December 2, 2016
Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Norbert-Claude Gorin, Myriam Labopin, Tomasz Czerw, et al.
Bone Marrow Transplantation
|
December 16, 2020
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Jaime Sanz, Myriam Labopin, Miguel A Sanz, et al.
Blood Advances
|
December 5, 2024
Trial eligibility, treatment patterns, and outcome for venetoclax-based therapy in AML: a prospective cohort study
Ofir Wolach, Itai Levi, Boaz Nachmias, et al.
European Journal of Haematology
|
March 25, 2023
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study
Ofrat Beyar Katz, Chava Perry, Sigal Grisariu-Greenzaid, et al.
Bone Marrow Transplantation
|
September 22, 2022
Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)
Eleni Gavriilaki, Myriam Labopin, Ioanna Sakellari, et al.
Haematologica
|
November 21, 2024
Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing
Yael Morgenstern, JongBok Lee, Yoosu Na, et al.
Page
of 11